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Abstract
Background: Merozoites of Plasmodium falciparum invadethroughseveralpathways using different RBC receptors.Field isolates
appear to use a greater variability of these receptors than laboratory isolates. Brazilian field isolates were shown to mostly utilize
glycophorin A-independent invasion pathways via glycophorin B (GPB) and/or other receptors. The Brazilian population exhibits
extensive polymorphism in blood group antigens, however, no studies have been done to relate the prevalence of the antigens
that function as receptors for P. falciparum and the ability of the parasite to invade. Our study aimed to establish whether
v a r i a t i o ni nt h eGYPB*S/s alleles influences susceptibility to infection with P. falciparum in the admixed population of Brazil.
Methods: Two groups of Brazilian Amazonians from Porto Velho were studied: P. falciparum infected individuals (cases); and
uninfected individuals who were born and/or have lived in the same endemic region for over ten years, were exposed to
infection but have not had malaria over the study period (controls). The GPB Ss phenotype and GYPB*S/s alleles were
determined by standard methods. Sixty two Ancestry Informative Markers were genotyped on each individual to estimate
admixture and control its potential effect on the association between frequency of GYPB*S and malaria infection.
Results: GYPB*S is associated with host susceptibility to infection with P. falciparum; GYPB*S/GYPB*S and GYPB*S/GYPB*s
were significantly more prevalent in the in the P. falciparum infected individuals than in the controls (69.87% vs. 49.75%;
P,0.02). Moreover, population genetics tests applied on the GYPB exon sequencing data suggest that natural selection
shaped the observed pattern of nucleotide diversity.
Conclusion: Epidemiological and evolutionary approaches suggest an important role for the GPB receptor in RBC invasion
by P. falciparum in Brazilian Amazons. Moreover, an increased susceptibility to infection by this parasite is associated with
the GPB S+ variant in this population.
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Introduction
Specificity of invasion of Plasmodium falciparum merozoites into
human red blood cells (RBCs) was the first indication that malaria
parasites possess ligands that recognize and interact exclusively
with receptors on the surface of the host RBCs [1]. The specificity
of malaria parasites for RBC depends on a number of ligand-
receptor interactions that are dynamic in P. falciparum and provide
a greater flexibility to the parasite to overcome the variability in
host RBCs and to evade immune responses. The P. falciparum
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16123merozoites invade through several pathways using different RBC
receptors. Receptors include the glycophorin A, B and C (GPA,
GPB and GPC), Band 3 and others (Receptors Y, E, Z and X),
whose molecular identity has not yet been determined [2]. Field
isolates have shown even greater variability than the laboratory
strains in which the known invasion pathways have been defined
[3–9]. Our initial studies of field isolates from Mato Grosso, Brazil
have revealed that these parasites differ from common laboratory
strains, and mostly utilized GPA-independent invasion pathways –
the so-called alternative invasion pathways via receptors such as
GPB, Receptor Y, Receptor Z and/or others [2].
The genetic polymorphisms of glycophorins or other known
receptors play an important role in the resistance to the invasion of
erythrocytes by P. falciparum [10–19]. In hyperendemic malaria
regions of Papua New Guinea deletions in Band 3 (SLC4A1D27)o r
in GPC (Ge phenotype, GYPCDex3) are highly prevalent and these
RBC phenotypes confer selective advantage on morbidity [13–19].
In vitro invasion of RBCs that have GPC deficiency is significantly
reduced but not eliminated [10,11,20–23].
The polymorphisms identified so far in the two other known P.
falciparum glycophorin receptors, GPA (GenBank M60707) and
GPB (GenBank M60708), have been shown to be only mildly
associated with the efficiency of P. falciparum invasion and they
conferred only partial protection against invasion of RBCs [24,25].
For example, the invasion of P. falciparum malaria of En(a2) (lack
of GPA) and S2s2U2 (lack of GPB) RBCs is significantly
reduced but not eliminated [10,11,20–23], presumably because
the parasites can use one or more of the other RBC receptors for
invasion.
The GYPA and GYPB genes code for Type I membrane RBC
proteins that carry antigens of the MNS blood group system. GYPA
has two codominant allelic forms, which determine the M or N
antigens at the N-terminus of GPA (
1SSTTG
5 for M and
1LSTTE
5 for N). GPB is identical to GPA
N for the first 26 amino
acids and, thus, also encodes the N antigen at the N-terminus.
GYPB also has two codominant alleles: GYPB*S and GYPB*s
corresponding to S and s antigens, respectively, on the RBC
surface. The Ss antigens are defined by an amino acid change at
position 29 [Met(S)/Thr(s)] of GPB and are displayed as the S+s2;
S2s+ or S+s+ phenotypes [26]. In addition to their sequence
homology, GYPA and GYPB recombination and gene conversion
hotspots have been identified, generating on the RBC surface
many different hybrid GYP gene products that encode GPB
bearing low-prevalence antigens like He and Dantu [27]. The
GP.Dantu glycophorin is specified by a hybrid gene whose N-
terminal sequence is encoded by the GYPB gene and C-terminal
sequence by the GYPA gene. In this hybrid, the genomic
breakpoint is located in its intron 4, a composite of GYPB and
GYPA [28]. The hallmark of GPB.He antigen is the change of the
N-terminal sequence (from
1LSTTE
5 for N to
1WSTSG
5 for He)
that abolishes the expression of the common N antigen. GP.He
isoform of GPB may or may not carry the S or the s antigen
depending on whether it associates with mutations that affect the
splicing of exon 4 [29]. Dantu invariably expresses s, albeit weakly.
The Dantu variant is prevalent in Africans; 4% vs. 0% in
Europeans [30,31]. The in vitro invasion of GP.Dantu RBCs by
P. falciparum is severely compromised [30,32].
Some other GYPB nucleotide changes are known to influence
the expression of S or s antigens on the RBCs [27,33]. The GPB U
antigen is defined by aa 33–39 [34]. Thus, a deletion of GYPB
exons 2–5 results in S2s2U2 phenotype; absence of GPB on the
RBCs. Although, the GPB U2 RBCs are also S2s2, approxi-
mately 16% of S2s2 RBCs are U+ (S2s2U+
var phenotype) and
encoded by a hybrid glycophorin gene [29]. Of these, ,23% are
associated with a variant GPB that usually expresses the He
antigen, albeit variably [35–37]. Nucleotide changes in or around
GYPB exon 5 were suggested to be its molecular origin [29].
Notably, a higher prevalence of the S2s2U2 phenotype is found
in Africa (2–8%); among the pygmies (20%) [38–40], up to 37% of
West Africans and ,1% of African Americans [41]. Africans also
have a higher prevalence of the Henshaw phenotype (S2s2U+
var
or GP.He phenotype) [27]. The prevalence of GP.He in African
Americans is 3% and up to 7% in people of African origin in
Natal, Brazil [27]. The existence of these GPB variants in people
of African origin has led to the speculation that these variants may
have been selected as a result of the relative resistance that they
confer against P. falciparum malaria. Recently, a new GYPB-A-B
recombinant allele (Morobe allele) was found in a highly endemic
area in Papua New Guinea [42], but its precise protective effect
has not been yet characterized. In South and SE Asia significantly
higher prevalence of antigens carried by GPA/GPB hybrids, such
as the MUT, MINY, HIL, Hop, St
a, Mur and Mi
a antigens, are
present (0.68–15% vs. 0% in Caucasian), some of which also affect
the expression of the GPB S antigen on RBC surface [27]. All
these recombinant variants, largely described by blood group
scholars, are consistent with the results of a genome wide survey
for Copy Number Polymorphisms (CNPs) in the human genome
developed using Comparative Genome Hybridization [43], which
identified the GYPB locus as a CNP in African populations. A
recent study have identified the P. falciparum ligand for GPB, which
raised the possibility that mutations in the gene encoding
Glycophorin B in malaria endemic areas could affect susceptibility
to malaria through the inability of the ligand to bind to the varied
receptor [44].
The Brazilian population exhibits extensive polymorphism in
blood group antigens. Although many of these are well
documented [45–47], no studies have been done to specifically
relate the frequencies of defined polymorphic blood group
antigens that function as receptors for P. falciparum and the ability
of the parasite to invade them. An uncontrolled GPB phenotype-
based study of four different ethnic groups in Colombia, suggested
an association between the GPB S2s+ variant and a greater
resistance to malaria (P. vivax and/or P. falciparum) in people of
African origin [48]. A study by Beiguelman et al. [49] in a rural
area of Rondo ˆnia was not able to substantiate the studies in
Colombia [48] as they did not find any significant associations
between GPB SS, Ss or ss phenotypes and Plasmodium infection
status. However, preliminary studies in four other endemic regions
of the Brazilian Amazon including Porto Velho of Rondo ˆnia also
observed higher frequencies of the GPB S+s+ phenotype among
P. falciparum malaria patients from Bele ´m and Rio Branco, while
higher frequencies of the GPB S2s+ phenotype were found in
uninfected blood donors from Bele ´m, Porto Velho, and Rio
Branco [50]. The discrepancy between the two studies in
Rondo ˆnia was attributed to potential differences of the populations
studied.
These preliminary studies pointed to a potential association
between GPB S+ carriers and their P. falciparum infection status,
although the significanceof these results was impacted by the lack of
control for ethnicity, a potential confounding factor. Therefore, our
present study in Porto Velho, Rondo ˆnia was aimed to further
establishwhethermolecularvariationintheGYPBgene,particularly
the one that generates the GYPB*S/s alleles, influences host
susceptibility to infection with P. falciparum, taking into account
the possible confounding factor of ethnicity. In addition, we
interpreted our results in the context of the coding nucleotide
diversity and haplotype structure of GYPB, which might also
influence the prevalence of P. falciparum infections in this population.
GYPB Polymorphism and P. falciparum Infection
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Ethics Statement
The research reported here was approved by the IRB of each of
the collaborating institutions Hemocentro, UNICAMP, State of
Sao Paulo; the Faculdade de Medicina, Sa ˜o Jose ´ do Rio Preto,
State of Sao Paulo; and the Universidade Federal do Rio de
Janeiro. The collaborating institutions are registered with the
OHRP (FWA00007713; FWA00000377; and FWA00003452,
respectively) and their IRB are also registered. The overall
protocol was also approved by the IRB from the New York Blood
Center (Protocol 415-05). A written informed consent was
obtained from all adults, as well as from the parents or legal
guardians of minors who participated in the present study.
Study population
Two groups of individuals have been recruited for this study
over the period of 2006–2007 in Porto Velho, Rondo ˆnia: 1)
P. falciparum infected individuals; and 2) uninfected individuals who
were born and/or have lived in the same endemic region for over
ten years, were exposed to infection but have not had malaria in
the past or over the 2–3 year study period. All consenting
individuals have been interviewed and information regarding their
gender, age, date of birth, place of birth, mother’s name and
maiden surname, ethnic origin of their parent and their
grandparents, length of residence in their present locality, history
of exposure and/or number of malaria episodes in the last 10
years, and past treatment for malaria were recorded.
Recruitment of P. falciparum infected individuals (N=83) was
done in the local healthcare clinic, Centro de Pesquisa em
Medicina Tropical (CEPEM), Porto Velho – Rondo ˆnia. The
consented individuals were of ranging age (18–62) and a female/
male ratio of 27/56 (Table 1). The blood samples of the consented
infected individuals were analyzed for P. falciparum parasitemia
using Giemsa stained thick blood smears. The density of
parasitemia in the infected individuals was recorded and expressed
as the number of asexual P. falciparum per microliter of blood
assuming a leukocyte count of 8000/ml. All patients with any
symptoms of malaria and/or microscopically confirmed infections
were given standard and appropriate treatment. The P. falciparum
treatments involved artemether-lumefantrine (CoartemH)o r
quinine-doxycycline therapy, the first-line anti-malarial therapies
recommended by the Brazilian Ministry of Health, which are
superior to other available and affordable treatments. DNA
prepared from whole blood samples was later analyzed by PCR for
parasite species specific genotyping using established protocols
[51] to confirm their infection status with the malaria parasites. It
appeared that only 32.3% of all the P. falciparum infected
individuals had mono-infection with P. falciparum; the majority of
the individuals had mixed infection with P. vivax (66.3%) or had a
triple infection with P. vivax and P. malariae (1.4%).
Active recruitment of the uninfected individuals who were born
and/or have lived in the same endemic region for over ten years
and have reported that they never had an episode of malaria
although their family members or neighbors had it (markers for
exposure) was done in the villages around Porto Velho (Ouro
Preto do Oeste, Guajara ´-Mirim, Ji-Parana ´ and Candeias do
Jamari). Those who met the inclusion criteria and consented to
participate were tested on site with the OptiMalH (DiaMed AG,
Switzerland), a rapid malaria diagnosis test, to validate their non-
infection status. Only those that were negative by the OptiMalH kit
were bled. To further verify the non-infection status of the
individuals in this study group, the DNA extracted from their
whole blood sample was later analyzed by PCR for parasite species
specific genotyping to identify those that might have asymptomatic
malaria infections or to confirm their malaria infection free status
using established protocols [51]. It appeared that 30 of the
individuals were PCR positive for malaria DNA; 27 of them had P.
vivax specific DNA and 7 had a mixed P. vivax and P. falciparum
DNA. These individuals were therefore excluded from the
uninfected control group but also were not included in the
infected group. The final control uninfected group constituted of
199 individuals; 18–56 years of age and a female/male ratio of 97/
102. A follow up of these individuals 2 years after the start of the
study confirmed that they still had no episodes of malaria in the
past or over the study period.
Phenotyping for GPB Ss blood group antigens
The presence of GPB Ss antigens on the surface of the RBCs
was detected by the hemagglutination test using specific gel cards
(Diamed AG, Morat, Switzerland) and appropriate commercial
antibodies. The testing was done using fresh blood from all
individuals from both study groups at the Blood Bank of Porto
Velho (Centro de Hemoterapia e Hematologia de Rondo ˆnia-
Fundac ¸a ˜o Hemeron/Hemotereapy and Hematology Center of the
Rondo ˆnia State – HEMERON Foundation) on the same day of
the blood collection.
Genotyping for GYPB*S/s
DNA samples of each individual were prepared from frozen
blood samples. Genomic DNA was isolated by a whole blood
DNA extraction kit (QIAmp, Qiagen, Valencia, CA) according to
the manufacturer’s instructions. The DNA solutions were analyzed
for quality by agarose gel electrophoresis. The GYPB* S/s
genotyping was performed using one or more of the following
assays:
Allele-specific PCR. Allele-specific PCR (AS-PCR) for the
GYPB*S/s alleles were performed in all samples. The sequences of
primer combinations and control primers that amplified an
unrelated gene (human growth hormone gene) were previously
published [29]. AS-PCR was carried out under the following
conditions: 16 PCR buffer, 1.5 mmol/L MgCl2, 0.2 mmol/L
dNTP mix, 100 ng of sense and antisense primers, 100 ng of
control primers, 2.5 U Taq DNA polymerase and ,50 ng of
genomic DNA per 50 ml of total volume. The amplification was
performed using a 35-cycles protocol, with an annealing
temperature of 62uC.
GYPB Exon 5 combination AS/PCR-RFLP assay. To
determine if the S allele was silenced, genomic DNA samples
from S2s+ samples genotyped as GYPB*S/s were amplified with
the GPB4/5, GPBIVS5 and GPB5T primers [29], using a
combination AS/PCR-RFLP assay to determine whether GYPB
is present or absent and to distinguish the variant GYPB genes
products in S2s+ (GYPB*S silent gene) individuals. The PCR
products were digested with EcoRI overnight at 37uC. The uncut
and digested products were analyzed on a 10% polyacrylamide
gel.
BeadChip DNA analysis. For some of the P. falciparum
infected and controls samples for which there was discordance
between the two genotyping methods described above and the
phenotyping by hemagglutination were re-tested for the GYPB*S/s
genotypes using a DNA array, BeadChip
TM Human Erythrocyte
Antigen (‘‘HEA’’), containing specific probes directed to
polymorphic sites in RHCE, FY (including FY-GATA and FY265),
DO (including HY and JO), CO, DI, SC, GYPA, GYPB (including
markers permitting the identification of U-negative and U-variant
types), LU, KEL, JK, LW and one mutation associated with
hemoglobinopathies (HgbS) (BioArray Solutions, Warren, NJ,
GYPB Polymorphism and P. falciparum Infection
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with a previously described protocol [52,53].
GYPB exon sequencing of GYPB. Specific PCR
amplification of GYPB is difficult because of its high homology
with the two distinct glycophorin genes, GYPA and GYPE.W e
therefore designed the GYPB-specific primers using the following
procedure: we aligned human GYPA (GenBank m60707), GYPB
(GenBank m60708), and GYPE (GenBank m29609) sequences and
identified sites that are variable and specific for GYPB gene
segments encompassing exons 2, 4, 5 and 6. The GYPB-specific
primers had to be at their 39 terminals sites 100% specific for their
own sequences. After PCR and sequencing, we verified the
identity of the PCR amplicon by verifying the presence of GYPB
specific sites. Primers used for PCR amplification contained a
M13F or M13R tails (Table 2) and their PCR products included
the respective exon and part of its flanking intron regions. PCR
amplification was done using 10 ng of genomic DNA, 200 nM of
each primer and Platinum PCR SuperMix (Invitrogen, Carlsbad,
CA, US) in final volume of 50 mL. The cycling profile used was
2 minutes at 94uC, 45 cycles of 30 seconds at 94uC, 45 seconds at
annealing temperature, 2 minutes at 72uC and a final extension of
5 minutes at 72uC. PCR products were purified and bi-
directionally sequenced using M13 forward or M13 reverse
primers and Applied Biosystem technology (Genewiz, NJ, US).
Sequences were analyzed using phred-phrap-consed software [54]
and the pipeline described by Machado et al. [55], using the
Genbank sequence NC_000004.11 as reference.
Genotyping a GYPB tagSNP using Taqman real time PCR
assay. To complement the sequencing data and obtain a better
coverage of the GYPB haplotype structure, we identified SNPs
from the HapMap (June 2009) database that were not included in
the re-sequenced regions (for example, intronic SNPs), were
common (MAF.0.10) and were polymorphic in at least one of the
HapMap population. We analyzed the pattern of linkage
disequilibrium across GYPB from HapMap data and selected
two tag-SNPs (that can be used as surrogate for untested SNPs,
due to the pattern of linkage disequilibrium): rs4835511 and
rs9685167. We genotyped them by TaqMan assays (Applied
Biosystems, Palo Alto, CA, US); rs9685167 genotyping did not
work properly, while rs4835511 did using 10 ng of genomic DNA,
TaqManH Genotyping Assay 206 and TaqManH Genotyping
Master Mix (Applied BiosystemsH, Foster City, CA, US) in final
volume of 10 mL.
Ancestry Informative Markers genotyping
We genotyped 62 Ancestry Informative Markers (AIMs) in the
DNA samples of all cases and controls. The first set of AIMs
consisted of 14 SNPs reported and genotyped in two multiplex
reactions as in Da Silva et al. [56] The second set of AIMs
included 48 INDELs reported and genotyped in three multiplex
reactions as in Santos et al. [57].
Statistical and population genetics analyses
We used the Fisher exact test to assess the Hardy-Weinberg
equilibrium. To measure association between S/s genotypes and
malaria infection we used the haplotype score test by Schaid et al.
[58] and Lake et al. [59] implemented in the software Haplostats
v.1.4, assuming dominance for the S allele and when necessary,
including age, gender, and African, European or Native American
Table 1. Demographic characteristics, ancestry estimations and GYPB*S/s genotype frequencies in cases and controls, tests for

















Controls (n=199) 28.29 (9.16) 97/102 0.18 (0.14) 0.54 (0.19) 0.28 (0.17) 15 (7.54) 84 (42.21) 100 (50.25) P=0.65
Cases (n=83) 31.76 (11.99) 27/56 0.18 (0.14) 0.54 (0.18) 0.28 (0.18) 3 (3.61) 55 (66.27) 25 (30.12) P,0.01
Total (n=282) 29.30 (10.16) 124/158 0.18 (0.14) 0.54 (0.19) 0.28 (0.17) Association test assuming dominance of S:
P,0.02**
*SD, standard deviation.
**Association persists (P,0.02) if age, gender and European, African or Native American ancestry are included as covariates.
doi:10.1371/journal.pone.0016123.t001
Table 2. Primers designed to amplify GYPB exons 2, 4, 5 and 6 by PCR.





Exon 2 M13F-Exon2-for TGTAAAACGACGGCCAGTGGACTGGAGGGATGTGAGA 55uC 402 bp
M13R-Exon2-rev CAGGAAACAGCTATGACCTAGAATTCCTCTGTAGTAA
Exon 4 M13F-Exon4-for TGTAAAACGACGGCCAGTGCATGGGACTGGCATCTC 60uC 722 bp
M13R-Exon4-rev CAGGAAACAGCTATGACCGCTTGGCCTCCCAAAATTATA
Exon 5 M13F-Exon5-for TGTAAAACGACGGCCAGTATAGTATGTTAACTGTACTTTG 48uC 393 bp
M13R-Exon5-rev CAGGAAACAGCTATGACCTCTATGTGTCCAGTTGAAAA
Exon 6 M13F-Exon6-for TGTAAAACGACGGCCAGTCAGAGGCTGAAGTGGAGTCT 55uC 276 bp
M13R-Exon6-rev CAGGAAACAGCTATGACCTAGAGAATACAGTAATAGTG
doi:10.1371/journal.pone.0016123.t002
GYPB Polymorphism and P. falciparum Infection
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developed keeping in mind haplotype analyses, the association test
(analogous to Fisher exact tests) is also suitable for single SNPs.
Individual European, African and Native American ancestry
were estimated using the Bayesian clustering algorithms developed
by Pritchard and implemented in the program STRUCTURE
v2.3.2 [60,61]. We assumed that three parental populations (K=3
clusters) contributed to the genome of the admixed individuals.
STRUCTURE estimates individual admixture conditioning on
Hardy-Weinberg and linkage equilibrium on each of the K=3
clusters, that represent the parental populations. We run the
program using a length of burn-in Period of 100 000 and 10 0000
repetitions of MCMC after burning. We used prior population
information for individuals from the parental populations to assist
clustering (USEPOPINFO=1) and assumed the admixture model
for individuals from the admixed populations, inferring the alpha
parameter for each population. We also used the parameters
GENSBACK=2 and MIGRPRIOR=0.05. Moreover, we as-
sumed that allele frequencies were correlated (i.e. similar across
parental populations) and that the parental populations show
different levels of differentiation (FST, with prior mean of 0.01 and
standard deviation of 0.05). The admixture in each group (cases
and controls) is calculated by Structure as the average of the
admixture for each individual within the group. We performed
these analyses with the two sets of data we produced for this study:
(1) the 48 INDELS previously used by Santos et al. [57], using the
ancestral populations reported in that publication, and (2) using 62
AIMs (those in Santos et al. [57] and the 14 SNPs reported by da
Silva et al. [56], using the parental populations from the latter
publication. Both measurements of ancestry were highly correlated
(Spearman correlation coefficients: 0.82, 0.89 and 0.92 for
African, European and Native American admixture, respectively,
with P always,0.01).
We inferred haplotypes considering SNPs with a Minor Allele
Frequency (MAF) $0.05, using the method by Stephens and
Scheet [62]. The recombination parameter r was also calculated
for each population by using the method of Li and Stephens [63].
These inferences were performed by the software Phase v.2.1.1.,
using 10.000 iterations, thinning intervals of 100 and burn in of
1000. Linkage disequilibrium (LD) was estimated by r
2 for SNPs
with MAF$0.05 in at least one population [64] and its
significance assessed by LOD scores, using software Haploview
v.3.2 [65].
For the analyses of the sequencing data, we assessed intra-
population variability using the following estimators of the h
parameter based on the infinite-site-model of mutations: p, the
per-site mean number of pair-wise differences between sequences
[66], and by hw, based on the number of segregating sites [67]. To
investigate if the observed patterns of variability in the studied
Brazilian population is consistent with the neutral model of
evolution, we used the statistical tests of Tajima’s D [68], Fu and
Li’s D* and Fu and Li ’s F* [69] on the re-sequencing data, testing
these statistics against the standard null hypothesis of neutrality (no
natural selection) under constant population size.
Results and Discussion
GYPB*S/s frequencies in the control and P. falciparum
infected populations
Two groups of individuals were studied; the uninfected group
(N=199) and the P. falciparum infected group (N= 83). Host DNA
from these individuals was used for GYPB*S/s genotyping by AS-
PCR, PCR-RFLP and/or DNA array analysis. Specific PCR
amplification of GYPB*S/GYPB*s is difficult because of the high
homology between GYPA, GYPB and GYPE. To have accurate
results we have chosen two different methods for GYPB*S/GYPB*s
genotyping: the allele-specific AS-PCR, an ‘‘in house’’ method,
and the HEA (i.e. Human Erythrocyte Antigen) BeadChip, a
microarray method commercially available. All samples were
analyzed by both methods. When the genotype results in an
individual were inconsistent using both methods, we excluded
these individuals from further analyses, even thought the HEA
BeadChip is known to be more accurate than the AS-PCR
[52,53]. Only 3 individuals had mismatching genotypes and were
not included in the association studies. Genomic DNA samples
from individuals phenotyped S2s+ but genotyped as GYPB*S/s
were analyzed using a combination AS/PCR-RFLP assay [29,70]
in order to determine if the S allele was silenced (GYPB*S silent
gene).
When the genotype distributions of GYPB*S/s alleles in the two
study groups were compared, the differences in the frequencies of
the GYPB*S/GYPB*S and GYPB*S/GYPB*s vs. GYPB*s/GYPB*s
genotypes between the P. falciparum infected individuals (cases) and
the uninfected individuals (control) were significant (69.87% vs.
49.75% of GYPB*S/GYPB*S and GYPB*S/GYPB*s and 30.1% vs.
50.25% of GYPB*s/GYPB*s, respectively; P,0.02, Odds Ra-
tio=1.55 with 95%CI=[1.02, 2.38]) (Table 1). In these analyses,
we assumed that the presence of the GYPB*S allele is a dominant
risk factor for susceptibility to infection (i.e., regardless if it is a
homozygote or heterozygote), as it results in the phenotypic
expression of GPB S+ on the surface of the RBCs. Intriguingly,
only the infected individuals do not fit the Hardy-Weinberg
expectation; with an excess of the heterozygous GYPB*S/GYPB*s
genotype (66.27%, Table 1) as compared to what was expected
(46.66%).
We observed a discordance of 5% between Ss phenotyping
(performed in the field) and genotyping, which is compatible with
previous studies [70]. Noteworthy, the results of phenotypes match
those of genotypes, both for the excess of S+s+ or GYPB*S/GYPB*s
heterozygous individuals among cases and for the association of
the presence of the GPB S+ or GYPB*S putatively dominant allele
with their infection status. Although GYPB, GYPA and GYPE
genotyping is associated with technical difficulties due to their
extensive sequence homology, the high concordance of our
phenotype and genotype results and the significance of the
association even when phenotypes are analyzed, suggest that our
genotyping results are robust.
Interestingly, we have found a higher frequency of heterozygous
GYPB*S/s genotypes among the P. falciparum infected individuals
(66.27% in cases versus 42.21% in controls). Considering that
heterozygous are more frequent that the homozygous S+s2,i t
seems that the amount of GPB S receptor molecules doesn’t
influence the susceptibility to P. falciparum infection. If we make an
analogy to the Duffy blood group (FY), the receptor for P. vivax,
and susceptibility of P. vivax malaria, different studies [20,71,72],
including one in the Amazonian region of Brazil [73], have
demonstrated that individuals with the FYA/FYB genotype have
higher susceptibility to malaria infection. The Fy gene has two
antigens (Fy
a and Fy
b) that are encoded by the co-dominant alleles
FYA and FYB, located on chromosome 1. The corresponding anti-
Fy
a and anti-Fy
b antibodies define four different phenotypes;
Fy(a+b+), Fy(a+b2), Fy(a2b+) and Fy(a2b2). The FYA and FYB
alleles differ by one nucleotide change in exon 2 encoding glycine
in Fy
a or aspartic acid in Fy
b at residue 42 [73]. In the Brazilian
study [73], the authors reported a larger number of malaria
episodes among patients with the heterozygote (FY*A/FY*B)
genotype than the homozygote (FY*A/FY*A or FY*B/FY*B)
genotypes. Individuals homozygous for FYA or FYB alleles
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for the P. vivax invasion, than those who were heterozygotes. Apart
from the different levels of the expression, the specific conforma-
tion of the Fy
a and Fy
b antigens may also determine differences in
the susceptibility to infection. Nevertheless, it was concluded that
one of the possible consequences of differential susceptibility to
P. vivax malaria could be modifications in allelic frequencies of
FY*A and FY*B in populations exposed to P. vivax, the most
prevalent malaria species in the Brazilian Amazon region.
Our study has verified for the first time that molecular variation
in the GYPB gene, particularly in the GYPB*S/s alleles, influenced
host susceptibility to infection with P. falciparum in Porto Velho,
Rondo ˆnia. In this study we took into consideration the possible
confounding factor of ethnicity by performing association analyses
adjusted for admixture, as well as for age and gender (Table 1). An
association between other human receptor polymorphisms and
variations in the parasite ligands of P. falciparum that modulate
susceptibility to malaria, was also demonstrated [25,74–76].
GYPB*S/s allele frequencies vary across human populations; the
GYPB*S allele (supposedly associated with infection) is less
common in East Asians (,10%) than in Sub-Saharan Africans
(.25%) and Europeans (,30–40%). Therefore, if the cases have
more European ancestry than controls; a false positive result may
emerge due to the association of any variant more common in
Europeans, and thus the association results we got might not be at
all related with susceptibility to infection conferred by the GPB Ss
blood group antigens. To avoid a false positive result, we also
measured the association among GPB Ss variants and infection by
controlling the effect of admixture. Because we ascertained that
African, European and Native American admixture do not differ
among cases and controls (Figure 1 and Table 1), we exclude the
possibility that our result is a spurious association. Controlling for
admixture is essential in genetic epidemiology studies performed in
Latin American populations, where large inter-individual differ-
ences in admixture are the rule [27].
We hypothesize that this Met29Thr polymorphism might be
associated with changes in the structure of the GPB molecule that
is used by P. falciparum to enter the RBCs. By having a Thr residue
(GPB s+) on the RBCs instead of a Met residue (GPB S+), GPB s+
gains potentially a new site for O-glycosylation, which can likely
alter its conformation and thus influence the efficiency of invasion
by the parasites and ultimately, susceptibility to infection.
Alternatively, this polymorphism may also affect dimerization of
GPB molecules with other GPB or with GPA molecules [77].
Population genetics of GYPB and inferences about
natural selection
In principle, the GYPB*S/s alleles might not be the only
functional GPB variants that modify P. falciparum invasion
efficiencies in the Brazilian population studied. To understand
the relationships between the observed association and the
haplotype structure of GYPB in this population, we sequenced
exons 2, 4, 5 and 6 of GYPB and their flanking regions, for a total
of 1492 bp in sub-samples of cases and controls, matching the
proportion of SS, Ss and ss genotypes observed in the total number
of cases and controls studied. These sequences are publicly
available under the GenBank accession numbers HQ639948–
HQ640229. This sub-sample includes 41 cases (2 SS, 26 Ss, 13 ss)
and 100 controls (8 SS, 42 Ss and 50 ss). We also used HapMap
data available in June 2009 to explore the pattern of linkage
disequilibrium across GYPB and selected the tag-SNP rs4835511
to be genotyped in the GYPB sequenced individuals using TaqMan
(Applied Biosystem) assay.
Table 3 shows the common GYPB haplotypes (i.e. a combina-
tion of alleles on the same chromosome) based on eight common
SNPs across the sequenced region and the tag-SNP rs4835511.
Haplotypes are sorted on the basis of their S/s (rs7683365) allele,
and Figure 2 shows that the S/s SNP is in linkage disequilibrium
with some common silent polymorphisms in exon 4 and its
adjacent introns, but not with all the common SNPs reported in
the GYPB sequenced regions. In particular, there is no linkage
disequilibrium between the S/s alleles (rs7683365) and the non-
synonymous common SNP rs1132783 (Ser/Thr) in exon 5. Since
this polymorphism is predicted by PolyPhen [78] as benign, we
assumed that its role in determining susceptibility to malaria
infection is minor in respect to the S/s allele; SNP rs1132783 is
located in the transmembrane domain of the protein, thus unlikely
to have an effect on the host-parasite interaction. The site-specific
PolyPhen algorithm (http://genetics.bwh.harvard.edu/pph/),
which uses protein structure and/or sequence conservation
information from each gene to predict whether a nonsynonymous
mutation is ‘‘benign,’’ ‘‘possibly damaging,’’ or ‘‘probably
damaging’’, was shown to be the best predictor of the fitness
effects of nonsynonymous mutations in a study analyzing a large
polymorphism data set from 301 human genes [79].
The pattern of nucleotide diversity of GYPB revealed by the
sequencing data is also informative about the role of the S/s alleles
in susceptibility to malaria infection, because it allows inferences
about the action of natural selection driven by malaria during the
human evolutionary history [80]. Inferences about the action of
natural selection have two implications. First, variants on genes
inferred to be under selection have contributed to determine
phenotype variability and perhaps, differential susceptibility to
diseases such as malaria. Second, by definition of natural selection,
these variants have been associated with relatively different
reproductive efficiencies (i.e. fitness) of their carriers, and therefore,
they have biomedical relevance. In particular for malaria, Ayodo
et al. [81] have evidenced that combining information from
Figure 1. Estimation of admixture using Ancestry Informative
Markers genotyping. Individual European, African and Native
American ancestry were inferred from 60 ancestry informative markers
in cases (magenta) and controls (yellow). Admixture was inferred by
comparison with individuals from the putative parental populations:
Europeans (red), African/African American (green) and Native Americans
(blue). Admixture was estimated using the software Structure and
average admixture over cases and controls is shown in Table 1.
doi:10.1371/journal.pone.0016123.g001
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selection increases the probability of identifying susceptibility
genes of malaria infection.
Analysis of GYPB nucleotide diversity in the Brazilian
population studied (Table 4) reveals that: (a) GYPB shows a level
of diversity that is similar to the most variable loci (ABO,
SERPINA5) observed in African populations [82]; the most diverse
continental human population. This is due in part to the genomic
structure of the glycophorins’ region, that encodes the GYPA,
GYPB and GYPE highly homologous genes, and which might be
affected by high rates of gene conversion among these loci. The
observed high diversity may also be due the admixed nature of the
Brazilian population, whose diversity reflects the combining effect
of the parental population’s diversity. (b) When the diversity of
GYPB is measured separately for haplotypes carrying S or s alleles,
diversity is consistently lower across cases and controls for the s
haplotypes (associated with resistance to infection) than for the S
haplotypes (associated with infection), notwithstanding the higher
frequency of the s allele, that being the most common in humans,
is expected to be the ancestral one, a condition typically associated
with higher nucleotide diversity.
The pattern of genetic diversity on a specific genomic region
depends both on the demographic history of populations, as well
as on locus specific evolutionary factors such as mutation,
recombination and natural selection. Almost 60 years ago,
Haldane [83] proposed the so-called ‘‘Malaria Hypothesis’’ - that
malaria might act as a selective force on human populations. Since
then, several studies have tested and verified this hypothesis in the
human host [81] and the malaria parasites [84,85]. To infer if
malaria-driven natural selection has shaped the diversity of GYPB,
we used statistical tests of the null hypothesis of neutrality: that the
GYPB pattern of diversity may be explained considering only the
demographic history of the studied population and mutation and
recombination patterns of GYPB, without the need to invoke the
action of other factors such as natural selection. These statistical
tests [68,69] (Tajima’s D and Fu-Li’s D* and F*) are based on the
proportion of rare and common polymorphisms expected in a
population under neutrality, and this proportion is informative
about natural selection. Table 4 shows that Tajima’s and Fu-Li’s
statistical tests are negative and significantly different from 0,
which is indicative of an excess of rare alleles in respect to neutral
expectations. This result is consistent with the following scenario
involving the action of natural selection (i.e. a selective sweep): a
beneficial substitution (putatively the s allele) rapidly increases in
Table 3. GYPB haplotype frequencies determined on the re-sequencing panel on the basis of common SNPs (MAF.0.05).
rs4835511 rs12499907 rs12499906 rs41338748 rs7662277 rs7683365
a rs7661933 rs1132783
b Cases Controls Total
Ancestral allele C T T T TC TG
GYPB-s1 T. . . .. .. 5 1 3 1 8
GYPB-s2 . . . . .. .. 37
c 109 146
GYPB-s3 . . . . .. .C 4 0 4
GYPB-s4 . . . A .. .C 6 1 9 2 5
GYPB-s5 . . . A .. .. 0 1 1
GYPB-S6 . G . . AT A. 1 1 2
GYPB-S7 . . G . AT A. 0 1 1
GYPB-S8 . G G . AT A. 2 6 4 9 7 5
GYPB-S9 . G G A AT A. 3 7 1 0
Number of chromosomes 82 200 282
aSNP accounting for S (Thr) and s (Met) phenotypes.
bSer(G)/Thr(C).
cThe modal haplotype in each group is underlined.
Non-synonymous substitutions are underlined.
doi:10.1371/journal.pone.0016123.t003
Figure 2. Linkage disequilibrium among common SNPs in
GYPB. Linkage disequilibrium among common SNPs in GYPB was
estimated in both study groups: the controls (a) and in the cases,
malaria infected individuals from Brazilian Amazon (b). Underlined SNPs
are non-synonymous substitutions: rs7683365 is the SNP determining S/
s antigens; rs1132783 is a Ser/Thr polymorphism (see Table 3).
doi:10.1371/journal.pone.0016123.g002
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through a hitchhiking effect. This process, driven by natural
selection, is too rapid for recombination to shuffle the surrounding
haplotype. As a consequence, it is expected that the nucleotide
diversity (p) of the haplotypes carrying the beneficial allele (s in this
case) is lower than the alternative allele (S), as observed in our data
(Table 4). During a selective sweep, rare substitutions become
common both because: the rise in frequency of the s haplotype;
other substitutions associated with S become rare; and new (and
therefore rare) substitutions appear in the expanding positively
selected haplotype. The negative values observed for the neutrality
tests for GYPB is consistent with this scenario (Table 4).
In the case of the Brazilian admixed population, the observed
excess of rare alleles in GYPB can not be a consequence of
admixture, which generally results in a reduced proportion of rare
alleles in respect to neutral expectations (and therefore, to positive
values of statistical tests such as D, D* and F*) [69]. Instead, we are
likely observing the signature of a selective sweep that occurred
during the last thousands of years of the human evolution in
malaria affected regions mainly in Southern Europe and more
likely Africa [86], where the ancestors of our studied Brazilian
population settled (see Table 1 for the predominant European
admixture proportion). Although our interpretation may be true
and consistent with the results of the present association study, an
unambiguous inference about the action of natural selection would
require a comparison of GYPB diversity with a set of other loci not
affected by natural selection, that would allow to obtain a more
realistic null neutral distribution of neutrality statistics (D, D*, F*)
that incorporate the specific demographic history of the studied
population. On the other hand, the lack of evidence of the action
of natural selection on African or European populations on
genomic screenings of signatures of natural selection [87–89] may
be due to the difficulties in genotyping/sequencing of the
glycophorins’ genomic regions.
Altogether, our results suggest that the S domain on GPB is
important for its binding to the specific ligand of the P. falciparum
parasite, EBL-1, which was recently identified and characterized
[44]. RBCs carrying glycophorin B but not RBCs lacking
glycophorin B (S2s2U2) were shown to adsorb the native
EBL-1 from P. falciparum culture supernatants. Future studies are
needed to demonstrate whether EBL-1 binds differentially to GPB
S2s+ vs. S+s+ RBCs, and thus indirectly substantiate at a
molecular level our observation of association studies at the
population level and our population genetics inferences about the
action of natural selection. Performing similar studies in other
regions of the Amazons and other endemic regions of the world is
also needed to further substantiate our observations; including
both association studies with larger sample sizes and with a
population genetics approach that include sequencing and
genotyping at a higher resolution. Because P. falciparum shows
also high population structure, in particular in the Amazon Region
[90], it is also important to understand the extent of variability in
host-parasite interaction and their co-evolution. The statistical
association between the presence of the S allele and infection
supports also the hypothesis that P. falciparum parasites in the
Brazilian Amazon regions utilize GPB as a key receptor for
invasion, and consequently individuals who carry distinct GYPB
gene variants, which might facilitate erythrocyte invasion, will be
more susceptible to P. falciparum infection. Thus, our results
reinforce the need of studies focusing on in vitro invasion assays
using erythrocytes with diverse GYPB genotypes and P. falciparum
strains from different origin to establish the role of the GPB
receptor for P. falciparum parasites of this region.
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